Stimulant Addiction Treatment: Cocaine, Meth, and Amphetamine Rehab

Stimulant use disorders — covering cocaine, methamphetamine, and prescription amphetamines like Adderall and Vyvanse — represent one of the most challenging categories in addiction medicine, partly because no FDA-approved medication exists specifically to treat them. Treatment instead draws on behavioral therapies, structured residential or outpatient programs, and close medical monitoring during withdrawal. This page maps the treatment landscape: what stimulant addiction actually is, how recovery programs address it, where people typically enter care, and how to think through which level of intensity is right for a given situation.

Definition and scope

Stimulant addiction is a substance use disorder (SUD) characterized by compulsive stimulant use despite harmful consequences — a diagnostic standard drawn from the DSM-5, published by the American Psychiatric Association. The three major drugs in this category operate by flooding the brain's dopamine system, but they differ meaningfully in duration, delivery route, and chemical profile.

Cocaine — derived from coca leaves and typically snorted, smoked as crack, or injected — produces a short, intense high lasting 15 to 30 minutes. That brevity drives bingeing patterns. Methamphetamine is a synthetic stimulant whose effects can last 8 to 12 hours, and its high potency is reflected in the damage it causes to dopamine-producing neurons with prolonged use (National Institute on Drug Abuse, Methamphetamine Research Report). Prescription amphetamines (Adderall, Vyvanse, Ritalin) have legitimate medical uses for ADHD and narcolepsy, but misuse — especially at escalating doses — produces a disorder that looks clinically similar to illicit stimulant addiction.

According to the 2022 National Survey on Drug Use and Health, approximately 1.6 million people in the United States met criteria for cocaine use disorder, and over 1.5 million met criteria for methamphetamine use disorder. These are not rare edge cases.

How it works

The absence of an approved pharmacotherapy for stimulant addiction means behavioral treatment carries most of the clinical weight. Two approaches have the strongest evidence base.

Contingency Management (CM) uses structured incentives — typically vouchers or small prizes — to reinforce stimulant-negative urine tests. Multiple randomized controlled trials have documented CM's effectiveness for cocaine and methamphetamine dependence, and a 2023 SAMHSA advisory formally recognized it as an evidence-based practice for stimulant use disorders.

Cognitive Behavioral Therapy (CBT) addresses the thought patterns and environmental triggers that sustain drug use. Sessions work through relapse prevention skills, refusal techniques, and restructuring beliefs around drug use. CBT is typically delivered in 12 to 16 individual sessions, though group formats exist.

The Matrix Model — a 16-week outpatient protocol developed specifically for stimulant disorders — combines CBT, family education, 12-step facilitation, and drug testing in a structured package. NIDA identifies it as one of the more comprehensive frameworks for methamphetamine and cocaine treatment. For a deeper look at how these therapies fit into the broader treatment architecture, the how it works page covers program structures in detail.

During withdrawal, stimulant users don't face the acute medical dangers associated with alcohol or opioid detox — no seizure risk, no respiratory depression. What they do face is a prolonged, uncomfortable crash: intense fatigue, dysphoria, hypersomnia, and drug craving that can peak around days 3 to 5 and persist in attenuated form for weeks. Medical oversight during this period isn't always mandatory, but it matters, particularly for heavy or long-term users.

Common scenarios

Stimulant addiction rarely arrives as a single isolated problem. Three presentations are particularly common.

1. Cocaine with alcohol co-use. These two substances are frequently used together, and the combination produces cocaethylene in the liver — a compound more cardiotoxic than either drug alone. Treatment programs need to address both substances simultaneously; treating only the cocaine component while ignoring alcohol dependence is a documented pathway to relapse.

2. Methamphetamine with co-occurring psychiatric disorders. Methamphetamine psychosis — paranoia, hallucinations, disorganized thinking — can persist weeks or months after last use, complicating diagnosis. Clinicians must distinguish drug-induced psychiatric symptoms from underlying schizophrenia or bipolar disorder, which requires time and stabilization. Dual diagnosis programs that integrate psychiatric and addiction treatment are standard of care for this presentation. The key dimensions and scopes of drug rehab page outlines what dual diagnosis programming typically includes.

3. Prescription amphetamine misuse in college-age adults. Often beginning as academic performance enhancement, misuse can escalate to physical dependence without the user identifying it as "real" addiction — a cognitive distortion that delays help-seeking. Outpatient CBT combined with ADHD evaluation (stimulant addiction and ADHD require careful clinical disentangling) is a common treatment path.

Decision boundaries

Choosing between outpatient, intensive outpatient (IOP), residential, and medically supervised detox depends on several overlapping factors. The American Society of Addiction Medicine's ASAM Criteria provides the standard framework clinicians use, assessing six dimensions including withdrawal risk, medical conditions, psychiatric comorbidities, and social environment.

A useful way to frame the decision:

• Outpatient (standard, 1–3 hours/week): Appropriate when social support is stable, no co-occurring disorders requiring intensive management, and the individual can maintain abstinence without round-the-clock structure.
• Intensive Outpatient (IOP, 9–20 hours/week): A strong fit for people who need more support than standard outpatient but have obligations — work, family, housing — that make residential impractical.
• Residential (28–90 days): Indicated when the home environment is a direct relapse trigger, when prior outpatient attempts have failed, or when co-occurring mental health conditions require close monitoring.
• Medical detox (inpatient stabilization): Primarily for severe withdrawal symptoms, suicidal ideation, or medical complications — less common with stimulants than with opioids or alcohol, but not absent.

Navigating these options is genuinely confusing, and the how to get help for drug rehab page walks through the practical steps of accessing an assessment and entering care. For common questions about costs, timelines, and what to expect from a program, the drug rehab frequently asked questions page covers the terrain most people encounter first.